Moneco Advisors, LLC Eli Lilly & CO Transaction History

Moneco Advisors, LLC

$1.02 Billion
Q2 2025

A detailed history of Moneco Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Moneco Advisors, LLC holds 4,142 shares of LLY stock, worth $3.57 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

4,142

Previous 4,123 0.46%

Holding current value

$3.57 Million

Previous $3.41 Million 5.2%

% of portfolio

0.32%

Previous 0.36%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$713.71 - $898.95 $13,560 - $17,080	19 Added 0.46%	4,142 $3.23 Million
Q1 2025 Aug 15, 2025	SELL	$725.72 - $929.72 $6,531 - $8,367	-9 Reduced 0.22%	4,123 $3.41 Million
Q1 2025 May 08, 2025	BUY	$725.72 - $929.72 $16,691 - $21,383	23 Added 0.56%	4,123 $3.41 Million
Q4 2024 Aug 15, 2025	SELL	$727.2 - $932.06 $7,272 - $9,320	-10 Reduced 0.24%	4,132 $3.19 Million
Q4 2024 Feb 03, 2025	BUY	$727.2 - $932.06 $627,573 - $804,367	863 Added 26.66%	4,100 $3.17 Million
Q3 2024 Oct 24, 2024	BUY	$772.14 - $960.02 $84,163 - $104,642	109 Added 3.48%	3,237 $2.87 Million
Q2 2024 Jul 19, 2024	SELL	$724.87 - $909.04 $724 - $909	-1 Reduced 0.03%	3,128 $2.83 Million
Q1 2024 Apr 25, 2024	BUY	$592.2 - $792.28 $58,035 - $77,643	98 Added 3.23%	3,129 $2.43 Million
Q4 2023 Mar 13, 2024	BUY	$525.19 - $619.13 $130,772 - $154,163	249 Added 8.95%	3,031 $1.77 Million
Q4 2023 Feb 05, 2024	BUY	$525.19 - $619.13 $129,721 - $152,925	247 Added 8.9%	3,023 $1.76 Million
Q3 2023 Mar 13, 2024	BUY	$434.7 - $599.3 $21,300 - $29,365	49 Added 1.79%	2,782 $1.49 Million
Q3 2023 Nov 03, 2023	BUY	$434.7 - $599.3 $20,430 - $28,167	47 Added 1.72%	2,776 $1.49 Million
Q2 2023 Mar 13, 2024	SELL	$350.74 - $468.98 $101,714 - $136,004	-290 Reduced 9.59%	2,733 $1.28 Million
Q2 2023 Aug 02, 2023	BUY	$350.74 - $468.98 $27,357 - $36,580	78 Added 2.94%	2,729 $1.28 Million
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $146,617 - $172,195	472 Added 21.66%	2,651 $910,000
Q4 2022 Jan 27, 2023	BUY	$321.55 - $374.67 $5,144 - $5,994	16 Added 0.74%	2,179 $797,000
Q3 2022 Nov 01, 2022	SELL	$296.48 - $337.87 $2,668 - $3,040	-9 Reduced 0.41%	2,163 $699,000
Q2 2022 Aug 10, 2022	BUY	$278.73 - $327.27 $188,142 - $220,907	675 Added 45.09%	2,172 $704,000
Q1 2022 May 09, 2022	BUY	$234.69 - $291.66 $14,785 - $18,374	63 Added 4.39%	1,497 $429,000
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $15,064 - $18,695	67 Added 4.9%	1,434 $351,000
Q3 2021 Nov 03, 2021	SELL	$221.6 - $272.71 $10,636 - $13,090	-48 Reduced 3.39%	1,367 $316,000
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $29,577 - $38,289	180 Added 14.57%	1,415 $264,000
Q4 2020 Jan 22, 2021	BUY	$130.46 - $172.63 $161,118 - $213,198	1,235 New	1,235 $229,000

Others Institutions Holding LLY

# of Institutions

4,470

Shares Held

779M

Call Options Held

16.9M

Put Options Held

12.6M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $820B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moneco Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moneco Advisors, LLC with notifications on news.

Account

Moneco Advisors, LLC Eli Lilly & CO Transaction History